Relationship between serum ferritin, erythrocyte sedimentation rate, mean corpuscular indexes and prognosis in patients with small cell lung cancer

Abstract

Abstract:ObjectiveTo explore the clinical value of serum ferritin (SF), erythrocyte sedimentation rate (ESR) and erythrocyte average indexes ［mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC)］ in the prognosis evaluation of patients with small cell lung cancer (SCLC). MethodsA total of 72 SCLC patients were enrolled in the Haian People′s Hospital Affiliated to Nantong University from January 2013 to October 2016 (SCLC group), and 80 health controls were selected at the same time (control group). The levels of serum SF, ESR and erythrocyte average indexes in SCLC group and control group were detected, and their relationships with clinical features, prognosis and survival time were analyzed. ResultsThe serum levels of SF, ESR, MCV, MCH and MCHC in SCLC patients were (309±59) μg/L, (16±4) mm/h, (104±12) fl, (32±4) pg and (307±21) g/L, respectively. The serum levels of SF, ESR, MCV, MCH and MCHC in control group were (186±26) μg/L, (15±5) mm/h, (85±7) fl, (30±3) pg and (335±25) g/L, respectively. Compared with the control group, the patients in SCLC group were significantly increased on the levels of SF (t=14.168, P<0.001) and MCV (t=6.143, P<0.001), and were significantly decreased on the level of MCHC (t=-4.220, P=0.003). There were no significant difference in the levels of ESR (t=1.931, P=0.102) and MCH (t=1.220, P=0.313) between the two groups. The serum levels of SF and MCV were significantly correlated with the stage of SCLC (t=-4.092, P=0.009; t=-4.985, P<0.001). Multivariate logistic regression analysis showed that high serum SF (OR=5.31, 95%CI: 3.099.31, P<0.001) and MCV (OR=1.78, 95%CI: 1.103.08, P=0.013) were independent risk factors of SCLC. Survival analysis showed that the survival time of the patients in the high SF group was significantly shorter than that in the low SF group (6 months vs. 20 months; χ2=6.556, P=0.001). ConclusionSerum ESR, MCH and MCHC levels are not significantly correlated with SCLC, but serum SF and MCV levels are of important clinical significance in evaluating the prognosis of SCLC patients.

Key words:Carcinoma, small cell,Lung neoplasms,Ferritins,Erythrocyte sedimentation rate

XIE Jin-Hua, JI Hao-Ming, CHEN Guo-Dong, WANG Yu, SHEN Yu-Cheng. Relationship between serum ferritin, erythrocyte sedimentation rate, mean corpuscular indexes and prognosis in patients with small cell lung cancer[J]. Journal of International Oncology, 2018, 45(8): 465-469.

References

［1］ Vallières E. Early stage small cell lung cancer: very rare, but a surgical disease!［J］. J Thorac Dis, 2017, 9(11): 41854186. DOI: 10.21037/jtd.2017.09.106. ［2］ Hung SK, Chen YC, Chiou WY, et al. Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a populationbased surgical cohort study［J］. BMJ Open, 2017, 7(9): e015022. DOI: 10.1136/bmjopen2016015022. ［3］张云飞, 晋学飞, 谭九峰, 等. 血清PSA与SF联合检测对诊断前列腺癌骨转移的意义［J］. 中国实验诊断学, 2017, 21(2): 259260. DOI: 10.3969/j.issn.10074287.2017.02.025. ［4］陈中青, 朱波, 赵惠柳, 等. 探讨血清癌胚抗原与铁蛋白联合检测对男性肺腺癌的诊断价值［J］. 中国卫生检验杂志, 2017, 27(3): 305307. ［5］ Kantor ED, Udumyan R, Signorello LB, et al. Adolescent body mass index and erythrocyte sedimentation rate in relation to colorectal cancer risk［J］. Gut, 2016, 65(8): 12891295. DOI: 10.1136/gutjnl2014309007. ［6］赖晓嵘, 黎莹, 杨冬阳, 等. 消化道肿瘤患者红细胞生成素水平的检测及其临床意义［J］. 肿瘤代谢与营养电子杂志, 2015, 2(1): 3941. ［7］ Yoon HJ, Kim K, Nam YS, et al. Mean corpuscular volume levels and allcause and liver cancer mortality［J］. Clin Chem Lab Med, 2016, 54(7): 12471257. DOI: 10.1515/cclm20150786. ［8］ Nakamura T, Takahashi M, Niigata R, et al. Changes in blood concentrations of trace metals in cancer patients receiving cisplatinbased chemotherapy［J］. Biomed Rep, 2016, 5(6): 737744. DOI: 10.3892/br.2016.789. ［9］ Koyama S, Fujisawa S, Watanabe R, et al. Serum ferritin level is a prognostic marker in patients with peripheral Tcell lymphoma［J］. Int J Lab Hematol, 2017, 39(1): 112117. DOI: 10.1111/ijlh.12592. ［10］ Isiksacan Z, Erel O, Elbuken C. A portable microfluidic system for rapid measurement of the erythrocyte sedimentation rate［J］. Lab Chip, 2016, 16(24): 46824690. DOI: 10.1039/c6lc01036a. ［11］周杏园, 严翠娥. 血清铁蛋白及4种肿瘤标记物联合检测对老年肺癌患者早期诊断价值分析［J］. 实用老年医学, 2016, 30(8): 657659. DOI: 10.3969/j.issn.10039198.2016.08.013. ［12］张国华, 张文波, 蒋鹏程. 长非编码RNA在胃癌中的研究进展［J］. 国际肿瘤学杂志, 2017, 44 (12): 937939. DOI: 10.3760/cma.j.issn.1673422X.2017.12.014. ［13］张予辉, 郭丽娟, 邝土光, 等. 红细胞沉降率和血清C反应蛋白水平与肺癌患病风险的关系［J］. 中华肿瘤杂志, 2010, 32(1): 4851. DOI: 10.3760/cma.j.issn.02533766.2010.01.012. ［14］ Zhang P, Nie X, Bie Z, et al. Impact of heavy smoking on the benefits from firstline EGFRTKI therapy in patients with advanced lung adenocarcinoma［J］. Medicine (Baltimore), 2018, 97(9): e0006. DOI: 10.1097/MD.0000000000010006.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	He Jiahui, Hu Qinyong.Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data[J]. Journal of International Oncology, 2024, 51(1): 29-36.
[3]	Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng.Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection[J]. Journal of International Oncology, 2023, 50(12): 711-716.
[4]	Chen Yu, Xu Hua, Liu Hai, Chen Shixin.Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging[J]. Journal of International Oncology, 2023, 50(11): 655-660.
[5]	Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun.Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model[J]. Journal of International Oncology, 2022, 49(9): 532-536.
[6]	Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying.Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses[J]. Journal of International Oncology, 2022, 49(8): 459-463.
[7]	Cai Gangxiang, Li Jing, Xu Bin.Advances in neoadjuvant immunotherapy for lung cancer[J]. Journal of International Oncology, 2022, 49(6): 366-370.
[8]	Zhang Jingxian, Yi Dan, Li Xiaojiang.Application of antibody-drug conjugates in the treatment of non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(5): 296-301.
[9]	Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei.Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer[J]. Journal of International Oncology, 2022, 49(4): 247-251.
[10]	Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu.Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(3): 140-145.
[11]	Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming.Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(2): 111-115.
[12]	Huang Huayu, Song Qibin, Gong Hongyun, Song Jia.Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy[J]. Journal of International Oncology, 2022, 49(12): 718-723.
[13]	Zhang Hongjiao, Jiang Jie, Huang Wei.Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis[J]. Journal of International Oncology, 2022, 49(1): 51-55.
[14]	Hu Ge, Su Jie, Li Qiangwei, Xu Peng, Xu Xiuli, Qian Xiaotao.Value of CD4/CD8 ratio and total B lymphocytes before radiotherapy in predicting radiation pneumonitis in patients with esophageal cancer and lung cancer[J]. Journal of International Oncology, 2021, 48(9): 523-526.
[15]	Wang Jun, Zhao Xia, Li Haifei, Zhang Cheng.Clinic diagnostic value of MSCT imaging features in nodular lung adenocarcinoma subtype[J]. Journal of International Oncology, 2021, 48(9): 537-543.